Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$360M |
| 2 |
NVIDIA
NVDA
|
+$324M |
| 3 |
Costco
COST
|
+$231M |
| 4 |
Amazon
AMZN
|
+$211M |
| 5 |
Johnson & Johnson
JNJ
|
+$158M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$299M |
| 2 |
Super Micro Computer
SMCI
|
+$284M |
| 3 |
JPMorgan Chase
JPM
|
+$178M |
| 4 |
Intel
INTC
|
+$161M |
| 5 |
WIRE
Encore Wire Corp
WIRE
|
+$160M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.67% |
| 2 | Financials | 17.53% |
| 3 | Industrials | 12.63% |
| 4 | Consumer Discretionary | 10.7% |
| 5 | Healthcare | 10.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3276
Corvus Pharmaceuticals
CRVS
$1.09B
| $63K | ﹤0.01% |
11,924
| – | – |
|
3277
Aterian
ATER
$12.5M
| $62.7K | ﹤0.01% |
+21,778
| New | +$65.1K |
|
3278
ReWalk Robotics
LFWD
$20M
| $62K | ﹤0.01% |
1,584
+455
| +40% | +$19.6K |
|
|
AFMD
3279
DELISTED
Affimed
AFMD
| $60.9K | ﹤0.01% |
+18,120
| New | +$79.9K |
|
3280
Stabilis Solutions
SLNG
$92.2M
| $60.6K | ﹤0.01% |
12,779
+2,166
| +20% | +$8.91K |
|
|
ME
3281
DELISTED
23andMe Holding Co
ME
| $60.5K | ﹤0.01% |
8,705
| – | – |
|
3282
Prelude Therapeutics
PRLD
$361M
| $60.3K | ﹤0.01% |
29,082
+8
| +0% | +$37 |
|
|
RDNW
3283
RideNow Group
RDNW
$220M
| $60K | ﹤0.01% |
12,533
-16,649
| -57% | -$68.8K |
|
3284
Milestone Pharmaceuticals
MIST
$115M
| $60K | ﹤0.01% |
39,450
| – | – |
|
|
ALLK
3285
DELISTED
Allakos
ALLK
| $58.8K | ﹤0.01% |
89,998
-36,644
| -29% | -$26.5K |
|
3286
Sono-Tek
SOTK
$70.7M
| $58.6K | ﹤0.01% |
14,529
-1,663
| -10% | -$6.73K |
|
3287
Marker Therapeutics
MRKR
$19.5M
| $57.2K | ﹤0.01% |
20,278
| – | – |
|
3288
Century Therapeutics
IPSC
$359M
| $56.9K | ﹤0.01% |
33,449
-41,866
| -56% | -$82K |
|
|
KLRS
3289
Kalaris Therapeutics
KLRS
$76.2M
| $56.3K | ﹤0.01% |
3,033
| – | – |
|
3290
Precigen
PGEN
$2.51B
| $54.1K | ﹤0.01% |
57,082
-1,673
| -3% | -$2.11K |
|
3291
iBio
IBIO
$76.5M
| $53.4K | ﹤0.01% |
+24,071
| New | +$47.5K |
|
3292
One Stop Systems
OSS
$215M
| $53.2K | ﹤0.01% |
22,257
| – | – |
|
3293
PharmaCyte Biotech
PMCB
$4.1M
| $52.7K | ﹤0.01% |
27,601
+2,005
| +8% | +$3.73K |
|
|
IAUX
3294
i-80 Gold Corp
IAUX
$1.46B
| $52K | ﹤0.01% |
44,847
+300
| +0.7% | +$314 |
|
3295
Lisata Therapeutics
LSTA
$13.9M
| $52K | ﹤0.01% |
17,340
+4
| +0% | +$13 |
|
3296
OPAL Fuels
OPAL
$56M
| $51.6K | ﹤0.01% |
14,126
| – | – |
|
3297
AYTU BioPharma
AYTU
$21.4M
| $51.3K | ﹤0.01% |
21,832
-1,719
| -7% | -$4.45K |
|
|
LEV
3298
DELISTED
The Lion Electric Company
LEV
| $51.3K | ﹤0.01% |
75,530
+300
| +0.4% | +$226 |
|
3299
BuzzFeed
BZFD
$87.5M
| $50.8K | ﹤0.01% |
19,068
+4
| +0% | +$11 |
|
3300
Edesa Biotech
EDSA
$39.7M
| $50.4K | ﹤0.01% |
11,333
| – | – |
|
Similar funds
Dimensional Fund Advisors's Q3 2024 Portfolio in Review
As of Q3 2024, Dimensional Fund Advisors held 3,437 positions worth $412B, up 7.7% from $383B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q3 2024: portfolio turnover was 4.4%. Dimensional Fund Advisors opened 64 new positions and exited 88, leaving the 3,437-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q3 2024 buy was Seadrill: 3,075,053 shares worth $122M.
- Dimensional Fund Advisors added most to Meta Platforms (Facebook) in Q3 2024, an estimated $360M increase.
- Dimensional Fund Advisors's biggest Q3 2024 reduction was Broadcom, cutting an estimated $299M.
- Dimensional Fund Advisors fully exited Super Micro Computer in Q3 2024, selling an estimated $284M.
- Dimensional Fund Advisors's ten largest holdings make up 15% of its $412B portfolio in Q3 2024.
- Dimensional Fund Advisors opened 64 new positions and closed 88 in Q3 2024.
- Dimensional Fund Advisors's portfolio value rose 7.7% quarter-over-quarter to $412B.
Based on Dimensional Fund Advisors's 13F filing for Q3 2024, filed 7 Nov 2024.